SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...

In the article that accompanies this editorial, Smith et al 9 examine the association between availability of molecular testing before treatment decisions and outcomes such as time to next treatment ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

Each May, Brain Cancer Awareness Month offers an opportunity to spotlight one of oncology’s most complex and underserved areas: brain and other central nervous system (CNS) cancers. While progress has ...

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based methods to comprehensive next-generation sequencing of both tissue and plasma, ...